Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Manufacturing
Pharma
Ascendis must wait 3 more months for FDA verdict on TransCon PTH
It’s been a long wait for Ascendis to score FDA approval for its hormone replacement therapy TransCon PTH. And now, it’ll take another three months.
Kevin Dunleavy
May 14, 2024 5:36pm
Lonza hints at CDMO rebound as it reaffirms 2024 guidance
May 14, 2024 10:22am
Aurobindo's Eugia tallies a 5th Form 483 in less than a year
May 14, 2024 9:40am
WuXi AppTec refutes claim of secret IP transfer in letter to DOD
May 13, 2024 3:00pm
Sanofi, Pfizer, AZ lead biopharma industry investment in France
May 13, 2024 11:00am
AGC plots around 100 layoffs amid tough business environment
May 10, 2024 11:40am